Treprostinil sodium, which has a metabolic half-life of two to four hours, is supplied as a solution in 20-mL multiple-entry vials for continuous subcutaneous administration at room temperature.
A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.
After hours: March 13 at 6:01:33 PM EDT Loading Chart for UTHR ...
After hours: 5:48:15 p.m. EDT Loading Chart for UTHR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback